2Dodds RA, Connor JR, James IE, et al. Human osteoelasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and cx vivo study of remodeling bonc[J]. J Bone Miner Res, 1995, 10(11): 1666- 1680.
5Nemoto H, Rittling SR. Yoshitake H, et al. Ostcopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues[J]. J Bone Miner Res, 2001.16(4) :652-659.
6Singhal H, Bautista DS, Tonkin KS, et al. Elevatyed plasma osteopontin in metastatic breast cancer associated with increased tumjor burden and decreased survival[J]. Clin Cancer Res, 1997, 3 (4) :605-611.
二级参考文献32
1MEIER C R, SCHMITZ S, JICK H. Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer[J]. Pharmacotherapy. 2002,22(3) :303 - 309.
2SHARPE C R,COOLET J P,MCNUTT M, et al. Nested case - control study of the effects of non-steroidal anti- inflammatory drugs on breast cancer risk and stage [J].Br-J-Cancer,2000,83(1): 112-20.
3GARCIA- RODRIGUEZ L A, HUERTA A C. Reduced risk of colorectal cancer anaong long - term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs[J]. Epidemiology , 2001,12( 1 ) : 88 -93.
4SMALLEY W,RAY W A, DAUGHERTY J ,et al. Use of nonsteroidal anti - inflammatory drugs and incidence of colorectal cancer: a population- based study[J]. Arch - Intern - Med, 1999, 159(2): 161 -166.
5ROSENBERG L, LOUIK C, SHAPIRO S. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma[J ]. Cancer,1998,82 (12) : 2 326 - 2 333.
6SHARPE C R, COOLET J P, MCNUTT M, et al. Nested case - control study of the effects of non - steroidal anti - inflammatory drugs on breast cancer risk and stage[J ]. Br- J - Cancer, 2000, 83 (1) : 112 -120.
7COOGAN P F, RAO S R, ROSENBERG L, et al. The relationship of nonsteroidal anti - inflammatory drug use to the risk of breast cancer[J]. Prev-Med,1999,29(2): 72-76.
8HARRIS R E,KASBARI S,FARRAR W B. Prospective study of non-steroidal anti- inflammatory drugs and breast cancer[J]. Oncol-Rep, 1999,6( 1 ) : 71 - 73.
9AKRE K, EKSTROM A M, SIGNORELLO L B, et al. Aspirin and risk for gastric cancer: a population- based case- control study in Sweden[J]. Br -J - Cancer,2001,84(7) : 965 - 988.
10ZARIDZE D,BORISOVA E, MAXIMOVITCH D,et al. Aspirin protects against gastric cancer: results of a ease - control study from Moscow, Russia[J ]. Int - J - Cancer, 1999,82 (4) : 473 - 476.
5Sobin DH and Witteking Ch(eds).TNM Classification of Malignant Tumours[M].6th ed.New York-Wiley-Liss,2002:199-202.
6Meerwitch K,Bergeron F,Lehloud L,et al.A novel RGD antagonist that targets both αvβ3 and α5β1 induces apoptosis of angiogenic endothelial cells on type I collagen[J].Vascu Pharm,2003,40(2),77-89.
7Hedley BD,Welch DR,Allan AL,et al.Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor1[J].Int Cancer,2008,123(3):526-534.
8Webber GF.The metastasis gene osteopontin:a candidate target for cancer therapy[J].Biochimica et Biophysica Acta,2001,(1552):61-85.
9Shirahama T,Arima J.Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder[J].Cancer,2001,92(1):188-193.
10Oksjima E U,Emura H.Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection[J].Ktuel Urol,2003,34 (4):256-258.
